The Penn Functional Radiation Medicine program is investigating low-dose radiation therapy as a treatment for osteoarthritis of the hip and knee.
The Davis Lab at Penn Neurology researches new approaches in invasive neurophysiology and neuroimaging for refractory epilepsy.
Clinicians at Penn Hematology Oncology are using innovative approaches for older adults ineligible for first-line therapy for acute myeloid leukemia.
Surgeons at Penn Medicine are using minimally invasive robotic approaches to treat hiatal hernia and the full spectrum of GI and abdominal disorders.
Drs. Ashley Newman and Ramy Sedhom review advances in breast cancer therapy and risk stratification in ductal carcinoma in situ (DCIS) management.
Penn Radiation-Oncology is conducting the first human feasibility clinical study in ConformalFLASH® proton therapy.
A less intense form of this mainstay of cancer treatment is now being applied to other conditions.
The Abramson Cancer Center’s legacy of holistic care is the foundation for cancer care and research that aims to become a model for the world.
A new initiative frees Penn primary care doctors from most on-call duties after work hours, while patients still have 24-hour access to virtual care.
